GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CellaVision AB (OSTO:CEVI) » Definitions » Market Cap

CellaVision AB (OSTO:CEVI) Market Cap : kr5,402.4 Mil (As of Dec. 14, 2024)


View and export this data going back to 2007. Start your Free Trial

What is CellaVision AB Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). CellaVision AB's share price for the quarter that ended in Sep. 2024 was kr293. CellaVision AB's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 23.9 Mil. Therefore, CellaVision AB's market cap for the quarter that ended in Sep. 2024 was kr6,988.5 Mil.

CellaVision AB's quarterly market cap increased from Mar. 2024 (kr5,700.5 Mil) to Jun. 2024 (kr5,974.8 Mil) and increased from Jun. 2024 (kr5,974.8 Mil) to Sep. 2024 (kr6,988.5 Mil).

CellaVision AB's annual market cap declined from Dec. 2021 (kr7,756.5 Mil) to Dec. 2022 (kr5,462.0 Mil) and declined from Dec. 2022 (kr5,462.0 Mil) to Dec. 2023 (kr5,056.5 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. CellaVision AB's Enterprise Value for Today is kr5,300.1 Mil.


CellaVision AB Market Cap Historical Data

The historical data trend for CellaVision AB's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellaVision AB Market Cap Chart

CellaVision AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,620.55 7,322.41 7,756.51 5,461.99 5,056.52

CellaVision AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,663.59 5,056.52 5,700.51 5,974.80 6,988.49

Competitive Comparison of CellaVision AB's Market Cap

For the Medical Devices subindustry, CellaVision AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellaVision AB's Market Cap Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CellaVision AB's Market Cap distribution charts can be found below:

* The bar in red indicates where CellaVision AB's Market Cap falls into.



CellaVision AB Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

CellaVision AB's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=kr212*23.8515
=kr5,056.5

CellaVision AB's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=kr293*23.8515
=kr6,988.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CellaVision AB  (OSTO:CEVI) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


CellaVision AB Market Cap Related Terms

Thank you for viewing the detailed overview of CellaVision AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


CellaVision AB Business Description

Traded in Other Exchanges
Address
Mobilvagen 12, Lund, SWE, 22362
CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers/software.

CellaVision AB Headlines

No Headlines